Form 4: Fairmount Funds Transfers Apogee Therapeutics Shares in Fund Restructuring

Fairmount Funds Management LLC reports the transfer of Apogee Therapeutics shares from Fairmount Healthcare Fund LP to Fairmount Healthcare Fund II LP as part of a fund wind down.

Summary

• Fairmount Funds Management LLC filed a Form 4 detailing changes in beneficial ownership of Apogee Therapeutics, Inc. [APGE] stock on March 28, 2024.
• The filing indicates a transfer of shares from Fairmount Healthcare Fund LP (Fund I) to Fairmount Healthcare Fund II LP (Fund II) due to the wind down of Fund I.
• 55,913 shares of common stock and 221,426 shares of non-voting common stock were transferred from Fund I to Fund II.
• Following the transaction, Fund II holds 2,048,647 shares of common stock and 6,743,321 shares of non-voting common stock.
• Tomas Kiselak and Peter Harwin, as Managing Members of Fairmount Healthcare Fund GP LLC and Fairmount Healthcare Fund II GP LLC, disclaim beneficial ownership except to the extent of their pecuniary interest.
• The non-voting common stock is convertible into common stock on a 1-for-1 basis, subject to a 9.99% ownership limit (which can be increased to 19.99% with notice).

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to internal fund restructuring. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

This filing reflects internal restructuring within Fairmount Funds and doesn't necessarily indicate a change in Apogee Therapeutics' overall prospects. Fund transfers are common in the investment management industry as funds mature or strategies evolve.

Stakeholder Impact

• The share transfer has minimal direct impact on Apogee Therapeutics' stakeholders, as it's an internal matter for Fairmount Funds.
• The ultimate beneficial ownership remains within the Fairmount Funds structure.

Key Dates